Cargando…

Effect of Multimorbidity on Health-Related Quality of Life in Adults Aged 55 Years or Older: Results from the SU.VI.MAX 2 Cohort

INTRODUCTION: Multimorbid chronic diseases are usually considered separately in trials. Here, we aimed to describe overall multimorbidity patterns in adults aged 55 years or older and assess their effect on health-related quality of life (HRQoL). METHODS: We used data for 5,647 participants included...

Descripción completa

Detalles Bibliográficos
Autores principales: Walker, Valentin, Perret-Guillaume, Christine, Kesse-Guyot, Emmanuelle, Agrinier, Nelly, Hercberg, Serge, Galan, Pilar, Assmann, Karen E., Briançon, Serge, Rotonda, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5199105/
https://www.ncbi.nlm.nih.gov/pubmed/28033414
http://dx.doi.org/10.1371/journal.pone.0169282
_version_ 1782488948470185984
author Walker, Valentin
Perret-Guillaume, Christine
Kesse-Guyot, Emmanuelle
Agrinier, Nelly
Hercberg, Serge
Galan, Pilar
Assmann, Karen E.
Briançon, Serge
Rotonda, Christine
author_facet Walker, Valentin
Perret-Guillaume, Christine
Kesse-Guyot, Emmanuelle
Agrinier, Nelly
Hercberg, Serge
Galan, Pilar
Assmann, Karen E.
Briançon, Serge
Rotonda, Christine
author_sort Walker, Valentin
collection PubMed
description INTRODUCTION: Multimorbid chronic diseases are usually considered separately in trials. Here, we aimed to describe overall multimorbidity patterns in adults aged 55 years or older and assess their effect on health-related quality of life (HRQoL). METHODS: We used data for 5,647 participants included in the SUpplémentation en VItamines et Minéraux AntioXydants 2 (SU.VI.MAX 2) population-based trial. HRQoL was assessed by the French versions of the Medical Outcome Study Short Form 36 and the Duke Health Profile. An exploratory factor analysis was used to determine multimorbidity patterns, and a multimorbidity score for each resulting pattern was calculated. Adjusted multiple linear regression was used to examine the association between the identified multimorbidity and HRQoL scores by gender and for each age group (55–59, 60–64, 65–69, ≥ 70 years). RESULTS: More than 63% of the sample reported two or more chronic conditions (from 55.8% for those 55–59 years to 74.4% for those ≥ 70 years). Multimorbidity was more common among women than men (67.3% vs 60%). Two different multimorbidity patterns were identified. Pattern A was represented mainly by mental illness and bone impairments. Pattern B was represented mainly by cardiovascular and metabolic disorders. After adjusting for covariates, a high pattern A score was associated with reduced HRQoL for the physical and mental components of each HRQoL questionnaire, and a high pattern B score was associated with reduced HRQoL for only the physical component of each questionnaire. These multimorbidity scores affected HRQoL differently by age group. CONCLUSION: Our study used a novel methodological approach to account for multimorbidity patterns in determining the link with chronic conditions. These multimorbidity scores (counted and weighted) can be used in clinical research to control for the effect of multimorbidity on patients’ HRQoL and may be useful for clinical practice. CLINICAL TRIAL REGISTRATION: Clinicaltrial.gov (number NCT00272428).
format Online
Article
Text
id pubmed-5199105
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-51991052017-01-19 Effect of Multimorbidity on Health-Related Quality of Life in Adults Aged 55 Years or Older: Results from the SU.VI.MAX 2 Cohort Walker, Valentin Perret-Guillaume, Christine Kesse-Guyot, Emmanuelle Agrinier, Nelly Hercberg, Serge Galan, Pilar Assmann, Karen E. Briançon, Serge Rotonda, Christine PLoS One Research Article INTRODUCTION: Multimorbid chronic diseases are usually considered separately in trials. Here, we aimed to describe overall multimorbidity patterns in adults aged 55 years or older and assess their effect on health-related quality of life (HRQoL). METHODS: We used data for 5,647 participants included in the SUpplémentation en VItamines et Minéraux AntioXydants 2 (SU.VI.MAX 2) population-based trial. HRQoL was assessed by the French versions of the Medical Outcome Study Short Form 36 and the Duke Health Profile. An exploratory factor analysis was used to determine multimorbidity patterns, and a multimorbidity score for each resulting pattern was calculated. Adjusted multiple linear regression was used to examine the association between the identified multimorbidity and HRQoL scores by gender and for each age group (55–59, 60–64, 65–69, ≥ 70 years). RESULTS: More than 63% of the sample reported two or more chronic conditions (from 55.8% for those 55–59 years to 74.4% for those ≥ 70 years). Multimorbidity was more common among women than men (67.3% vs 60%). Two different multimorbidity patterns were identified. Pattern A was represented mainly by mental illness and bone impairments. Pattern B was represented mainly by cardiovascular and metabolic disorders. After adjusting for covariates, a high pattern A score was associated with reduced HRQoL for the physical and mental components of each HRQoL questionnaire, and a high pattern B score was associated with reduced HRQoL for only the physical component of each questionnaire. These multimorbidity scores affected HRQoL differently by age group. CONCLUSION: Our study used a novel methodological approach to account for multimorbidity patterns in determining the link with chronic conditions. These multimorbidity scores (counted and weighted) can be used in clinical research to control for the effect of multimorbidity on patients’ HRQoL and may be useful for clinical practice. CLINICAL TRIAL REGISTRATION: Clinicaltrial.gov (number NCT00272428). Public Library of Science 2016-12-29 /pmc/articles/PMC5199105/ /pubmed/28033414 http://dx.doi.org/10.1371/journal.pone.0169282 Text en © 2016 Walker et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Walker, Valentin
Perret-Guillaume, Christine
Kesse-Guyot, Emmanuelle
Agrinier, Nelly
Hercberg, Serge
Galan, Pilar
Assmann, Karen E.
Briançon, Serge
Rotonda, Christine
Effect of Multimorbidity on Health-Related Quality of Life in Adults Aged 55 Years or Older: Results from the SU.VI.MAX 2 Cohort
title Effect of Multimorbidity on Health-Related Quality of Life in Adults Aged 55 Years or Older: Results from the SU.VI.MAX 2 Cohort
title_full Effect of Multimorbidity on Health-Related Quality of Life in Adults Aged 55 Years or Older: Results from the SU.VI.MAX 2 Cohort
title_fullStr Effect of Multimorbidity on Health-Related Quality of Life in Adults Aged 55 Years or Older: Results from the SU.VI.MAX 2 Cohort
title_full_unstemmed Effect of Multimorbidity on Health-Related Quality of Life in Adults Aged 55 Years or Older: Results from the SU.VI.MAX 2 Cohort
title_short Effect of Multimorbidity on Health-Related Quality of Life in Adults Aged 55 Years or Older: Results from the SU.VI.MAX 2 Cohort
title_sort effect of multimorbidity on health-related quality of life in adults aged 55 years or older: results from the su.vi.max 2 cohort
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5199105/
https://www.ncbi.nlm.nih.gov/pubmed/28033414
http://dx.doi.org/10.1371/journal.pone.0169282
work_keys_str_mv AT walkervalentin effectofmultimorbidityonhealthrelatedqualityoflifeinadultsaged55yearsorolderresultsfromthesuvimax2cohort
AT perretguillaumechristine effectofmultimorbidityonhealthrelatedqualityoflifeinadultsaged55yearsorolderresultsfromthesuvimax2cohort
AT kesseguyotemmanuelle effectofmultimorbidityonhealthrelatedqualityoflifeinadultsaged55yearsorolderresultsfromthesuvimax2cohort
AT agriniernelly effectofmultimorbidityonhealthrelatedqualityoflifeinadultsaged55yearsorolderresultsfromthesuvimax2cohort
AT hercbergserge effectofmultimorbidityonhealthrelatedqualityoflifeinadultsaged55yearsorolderresultsfromthesuvimax2cohort
AT galanpilar effectofmultimorbidityonhealthrelatedqualityoflifeinadultsaged55yearsorolderresultsfromthesuvimax2cohort
AT assmannkarene effectofmultimorbidityonhealthrelatedqualityoflifeinadultsaged55yearsorolderresultsfromthesuvimax2cohort
AT brianconserge effectofmultimorbidityonhealthrelatedqualityoflifeinadultsaged55yearsorolderresultsfromthesuvimax2cohort
AT rotondachristine effectofmultimorbidityonhealthrelatedqualityoflifeinadultsaged55yearsorolderresultsfromthesuvimax2cohort